All News

Found 784,788 articles

• Memory Pharmaceuticals Commences Phase 2a Trial Of MEM 1003 In Alzheimer's Disease

  11/4/2005

• Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Initiates Trial Of Novel Aurora Kinase Inhibitor MLN8054 In Advanced Solid Tumors

  11/4/2005

• Osta Biotechnologies Inc. Announces Promising Interim Results From Its Second Clinical Study On The Development Of A Novel Blood Test For Osteoporosis

  11/4/2005

• Osiris Therapeutics, Inc. Reaches Safety Milestone In Stem Cell Clinical Trial For Cardiac Patients

  11/4/2005

• Kensey Nash Corporation Announces Commencement Of Carotid Trial In Europe Using The TriActiv(R) ProGuard(TM) System

  11/4/2005

• CV Therapeutics, Inc. Announces Presentations At American Heart Association Scientific Sessions 2005

  11/4/2005

• Generex Biotechnology Corporation Scientist Presents Results Of Pandemic Influenza Vaccine Program At Washington Conference Highlighting Strategic Advances In Vaccines

  11/4/2005

• DOV Pharmaceutical To Present At The 8th International Conference On The Mechanisms And Treatment Of Neuropathic Pain

  11/4/2005

• Alba Therapeutics Corporation And The University of Maryland Report The Role Of Zonulin And Intestinal Permeability in Celiac Disease

  11/4/2005

• Array BioPharma, Inc. Announces Drug Discovery Collaboration With Ono Pharmaceutical Company, Ltd.

  11/4/2005

• Cytori Therapeutics, Inc. Enters Strategic Regenerative Medicine Collaboration With Olympus Corporation

  11/4/2005

• Clarient, Inc. Enters Into Master Service Agreement With Pfizer Inc.

  11/4/2005

• Reata Pharmaceuticals, Inc. Announces Receipt Of SBIR Grant For Discovery Platform; Grant Supports Discovery Of Small Molecules To Treat ALS

  11/4/2005

• Veterans Affairs Medical Center Awarded Contract To Service Sysmex America, Inc. In Mid Atlantic States

  11/4/2005

• Medical Services International Inc. Adds More Distributors To Its Distribution Network

  11/4/2005

• Cyberkinetics Neurotechnology Systems, Inc., Engages The Investor Relations Group, Inc., Of New York

  11/4/2005

• New Source MDx Patent Represents First Known Claim To "Normal" Ranges For Gene Expression, Grants Use For Development Of Biomarkers, Disease Diagnostics

  11/4/2005

• Cygnus, Inc. Announces That It Intends To File Certificate Of Dissolution On November 21, 2005

  11/4/2005

• Cell Therapeutics, Inc. Completes $82 Million Convertible Senior Notes Offering

  11/4/2005

• Myriad Genetics, Inc. Announces Pricing Of Common Stock Offering

  11/4/2005